Stenobolic (SR-9009) 10 mg Driada Medical
Overview of Stenobolic (SR-9009) 10 mg Driada Medical, history and composition
Stenobolic, commonly known as SR-9009, is an experimental compound that has garnered attention in the realm of sports pharmacology due to its purported performance-enhancing properties. Developed by Professor Thomas Burris at the Scripps Research Institute, SR-9009 functions as a Rev-ErbA ligand, modulating the circadian rhythm and metabolic processes in mammals. The compound is primarily available in a 10 mg dosage made by Driada Medical, a reputable name in the field of synthetic supplements. Composed of unique molecular structures that closely resemble steroid frameworks, SR-9009 is tailored for athletes seeking to optimize physical performance and endurance while potentially minimizing the impact of fatigue on training sessions.
Physiological impact, what happens in the body
Upon administration, Stenobolic interacts with Rev-ErbA proteins, leading to various physiological changes. One of the most striking effects is the enhancement of cellular metabolism and an increase in fat oxidation. This accelerates the body’s ability to utilize fat stores for energy, thereby potentially aiding weight loss and improving body composition. Furthermore, SR-9009 is believed to stimulate the production of mitochondria within muscle cells, enhancing stamina and facilitating longer training durations without the associated fatigue. Research suggests that it may also influence glucose metabolism and help maintain lower blood sugar levels, which can be beneficial for overall health and performance.
How to acquire Stenobolic (SR-9009) 10 mg Driada Medical, purchasing instructions
Acquiring Stenobolic (SR-9009) 10 mg Driada Medical can be straightforward if approached cautiously and knowledgeably. It is essential to purchase from reputable online suppliers or pharmacies to ensure product authenticity and quality. Verify that the vendor provides third-party testing and clear documentation to guarantee that you receive a legitimate product. Additionally, consider reading customer reviews and researching the vendor’s standing in the sports pharmacology community. When ready to purchase, follow these steps: select your desired quantity, ensure the product is in stock, and proceed through a secure payment process. It’s advisable to consult with a healthcare professional before starting any new supplement regimen.
Contraindications, who should avoid it
While Stenobolic has many positive effects, it is not suitable for everyone. Individuals with existing health conditions such as liver dysfunction, cardiovascular issues, or hormonal imbalances should avoid using this compound. Pregnant or nursing women, as well as minors, should also refrain from using SR-9009 due to insufficient research on its long-term effects in these groups. Always consult a healthcare provider prior to beginning any new supplement, especially if you are taking medications or have pre-existing health concerns.
Key effects, main reasons for use
The primary appeal of Stenobolic (SR-9009) lies in its ability to enhance athletic performance and promote fat loss. Users report several key effects, making this compound particularly attractive in the sports community:
- Improved endurance, allowing for more extended and productive training sessions.
- Increased metabolic rate, facilitating quicker fat loss and better body composition.
- Enhanced recovery, helping to minimize downtime post-training.
- Potential stabilization of blood sugar levels, contributing to overall health.
In summary, Stenobolic (SR-9009) serves as a promising supplement for athletes looking to enhance performance, although careful consideration and regulations are essential for safe use.
| Active substance | Stenobolic |
|---|---|
| Release form | Pack (25 Pills) |
| Water Retention | No significant water retention |
| Hepatotoxicity | Not enough data to determine |
| Lab Test | Specific tests for detection in blood or urine not widely detailed |
| Also known as | SR9009, Stenabolic |
| Blood pressure | No significant impact reported |
| Trade name | Not available under any trade name as it is not commercially marketed |
| Storage conditions | Store at room temperature away from moisture and light |
| Chemical name | Ethyl 3-[[(4-chlorobenzyl)((5-nitrothiophen-2-yl)methyl)amino]methyl]pyrrolidine-1-carboxylate |
| Formula | C20H24ClN3O4S |
| Substance class | Synthetic drug, Rev-ErbA ligand |
| Main action | Activates Rev-ErbA which increases mitochondrial count in muscle, decreases fat storage |
| Half-life | Approximately 4-5 hours |
| Dosage (medical) | Not clinically approved for medical use |
| Dosage (sports) | Typically 10-40 mg per day |
| Effects | Increased endurance, reduced fat mass, increased wakefulness |
| Side effects | Potential alterations in circadian rhythms, limited data on long-term effects |
| Use in sports | Used as a performance-enhancing drug, not approved by WADA |
| Active ingredient, mg | 10 |
| 1 Pill, mg | 10 |
| Manufacturer | Driada Medical |
| Packing | Packaging (50 tablets) |
| 5 |
|
0 |
| 4 |
|
0 |
| 3 |
|
0 |
| 2 |
|
0 |
| 1 |
|
0 |



Reviews
There are no reviews yet.